No long-term heart risks from breast radiation, study suggests

Study: no long-term heart risks from breast radiation
Findings based on 50 cancer survivors who were followed for 25 years.

(HealthDay)—A new study allays concerns that early-stage breast cancer patients who receive radiation treatment might have a long-term increased risk for heart problems.

The study included 50 stage 1 and stage 2 who underwent either breast-conservation therapy using radiation (26 patients) or modified radical mastectomy (24 patients). Mastectomy is a type of surgery that involves removing the breast.

More than 25 years after treatment, both groups had similar levels of heart function and rates of heart problems. For example, the rate of heart attack within 10 years of breast cancer diagnosis and treatment was 5.1 percent for breast-conservation patients and 5.7 percent for mastectomy patients.

The study was scheduled for presentation Monday at the annual meeting of the American Society for in Boston.

"Over the past two decades, radiation therapy has become more precise and safer with modern techniques," lead author Dr. Charles Simone II, a at the Hospital of the University of Pennsylvania in Philadelphia, said in a society news release.

"We are pleased to find that early-stage breast cancer patients treated with modern radiation therapy treatment planning techniques do not have an increased risk of long-term and that breast-conservation therapy with radiation should remain a standard treatment option," he added.

The data and conclusions of research presented at medical meetings are typically considered preliminary until published in a peer-reviewed medical journal.

More information: The U.S. National Cancer Institute has more about breast cancer treatment.

add to favorites email to friend print save as pdf

Related Stories

Radiation after mastectomy improves breast cancer survival

Jun 02, 2010

Postmastectomy radiation therapy (PMRT) for some breast cancer patients can reduce their risk of recurrence by almost 30 percent and increase their five-year overall survival by almost 50 percent, according to a study in ...

Recommended for you

How a common antacid could lead to cheaper anti-cancer drugs

10 hours ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.